Addendum to 23rd WHO Regulatory Update on COVID-19
4 December 2020
| COVID-19: Scientific brief
Overview
The UKs medicine licensing authority (MHRA) has issued an emergency use authorization for the Covid-19 vaccine BNT162b2 supplied by Pfizer and BioNTech. WHO has received the data on the vaccine from the manufacturer and is reviewing it for possible listing for emergency use.
WHO Team
Regulation and Prequalification (RPQ),
Regulation and safety (REG)
Number of pages
10